2 completed, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Timothy Morgan, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pegfilgrastim in Patients With Alcoholic Hepatitis Standard of care + pegfiltrastim, Standard of care - Alcoholic Hepatitis | Phase 2 | Completed | Timothy Morgan, MD | 34 | 2017-01-21 | 2021-09-29 |
| Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus DCV/ASV/BMS-791325, DCV/ASV/BMS-791325 + RBV - Hepatitis C | Not applicable | Completed | Timothy Morgan, MD | 25 | 2014-07-01 | 2016-04-19 |
| Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 Telaprevir, Peginterferon alfa-2a, Ribavirin - Hepatitis C | Phase 2 / Phase 3 | Withdrawn | Timothy Morgan, MD | 2013-08-01 | 2014-05-14 |
Hepatitis C (2) · Digestive System Diseases (1) · Hepatitis (1) · Hepatitis C, Chronic (1) · Hepatitis, Alcoholic (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1) · Liver Cirrhosis, Alcoholic (1) · Liver Diseases (1) · RNA Virus Infections (1)
Ribavirin (2) · Prednisolone (1) · Standard of Care (1) · Vitamin D (1) · daclatasvir (1) · pegfilgrastim (1) · peginterferon alfa-2a (1) · telaprevir (1)
United States (3)
Timothy R Morgan, MD (1) · Timothy R. Morgan, MD (1)
U01AA021886 (1)